NEWS
Catch up on the news and updates driving change and inspiring discovery across our fields.
AlphaFold: transforming protein research for Australian scientists
The 2024 Nobel Prize in Chemistry was awarded to the team behind the transformative AI tool AlphaFold. In a major achievement for life sciences and biomedical research, the tool developed by DeepMind and released in 2020 enables rapid, accurate prediction of protein...
Australian Grasslands Initiative – Request for Partnership 2024/2025
We are excited to announce the opening of the Request for Partnership for the Australian Grasslands Initiative. This collaborative effort seeks to unravel the complexities of Australia’s rangeland grasses, which have evolved to dominate vast areas of the continent,...
Annual Report 2024
Bioplatforms Australia, enabled by NCRIS investment in research infrastructure, is committed to supporting the Australian life sciences community through a diverse access program, provision of targeted infrastructure requirements, and making integrated capability...
Australian Fish Genomics Initiative: 2024 Request for Partnership Now Open
Bioplatforms Australia, in collaboration with Minderoo Foundation, is pleased to announce the opening of the 2024 Request for Partnership for the Australian Fish Genomics Initiative. This national initiative seeks to advance our understanding of Australia’s marine and...
EMBL Australia joins NCRIS Health Group to enhance collaborative health research
EMBL Australia has signed a Memorandum of Understanding (MOU) to join the NCRIS Health Group, strengthening Australian collaborative health research. The NCRIS Health Group, supported by the Australian Government’s National Collaborative Research Infrastructure...
Plant Pathogen Initiative – Request for Partnership 2024 is now open
The Bioplatforms Australia-supported Plant Pathogen ‘Omics Initiative was initiated in 2022 and is working to generate a national library of ‘omics data to support the goals and missions of the plant health community in preparing for, managing and...
Major breakthrough in type 1 diabetes: PromarkerD predicts kidney disease
Proteomics International Laboratories has released a groundbreaking study showing that its PromarkerD predictive test can effectively forecast renal decline in patients with type 1 diabetes. This exciting development, presented at the recent Australasian Diabetes...
Parliamentary Friends of Science event highlights Australia’s synthetic biology future
At a recent Parliamentary Friends of Science event in Canberra, synthetic biology took centre stage as a transformative force ready to reshape industries and tackle global challenges. Held at Parliament House, this gathering attracted scientists, policymakers, and...
Genomic research and Indigenous knowledge collaborate to protect the greater bilby
A new study published in Nature Ecology & Evolution has combined genomic research and Indigenous knowledge to enhance conservation efforts for the greater bilby, also known as Ninu (Macrotis lagotis), a culturally and ecologically significant marsupial...
Pioneering Australian vaccine innovation in the wake of Covid-19
The emergence of COVID-19 and the ensuing pandemic have demonstrated the ongoing threat that infectious diseases pose to our health, economy, and lifestyle. While traditional vaccines often take years to develop, the urgency of the pandemic has redefined expectations,...
Drug Target Identification node establishment at the Monash Proteomics and Metabolomics Platform
To bring new therapeutics into clinical use, understanding their mechanisms of action is essential. However, many drug candidates identified through phenotypic screening do not have known targets. To overcome this challenge, the Australian drug discovery landscape...
Advancing human genomics research through enhanced data sharing
Human genome sequencing and analysis have significantly contributed to understanding the causes of complex diseases, improving diagnostics, enabling early disease detection, and offering more tailored treatment options. Although Australia has seen a proliferation of...
Celebrating conservation and innovation in the 2024 Eureka Prizes
Bioplatforms Australia is proud to announce the remarkable achievements of its affiliated projects and researchers, who have been named finalists in the prestigious 2024 Eureka Prizes. The Threatened Species Initiative At the forefront of Bioplatforms’...
Response to Australia RNA blueprint
The NCRIS Health Group warmly welcomes the release of Australia’s RNA Blueprint by the Australian Department of Industry, Science and Resources. The NCRIS Health Group includes Bioplatforms Australia, EMBL Australia, National Imaging Facility, Phenomics Australia,...
Integrated Pest Management Omics Initiative request for partnership 2024 now open
We are pleased to announce the first Request for Partnership for the Integrated Pest Management ‘Omics Initiative (IPM OMICS). The IPM OMICS Initiative aims to build a foundation of molecular data to advance our understanding of Australia’s insects and...
Threatened Species Initiative request for partnership 2024 now open
TSI is now seeking partnerships as part of its Genomics Library program. This program seeks to create a foundation of genomic data to advance our understanding of key threatened species in Australia (fauna and flora) by developing best-practice reference genomes, and...
Advancing melanoma screening through personalised risk scores
Melanoma is the third most commonly diagnosed cancer in Australia. It is the leading cause of cancer-related deaths among young Australians. Bioplatforms Australia has provided long-term support for this major public health challenge. Our past involvements enabled the...
Australian advantage in advanced bio-manufacturing and synthetic biology
The Australian Prime Minister Anthony Albanese recently presented his vision for the Australian advanced manufacturing sector in a landmark ‘Future Made in Australia’ speech. Distinguished Professor Ian Paulsen, Australian Research Council Centre of...
Australia contributes to the global tree of life for flowering plants
The Genomics for Australian Plants Framework Initiative (GAP) consortium, formed by Bioplatforms Australia in partnership with researchers from the Australian State and National Herbaria and Botanic Gardens are proud to be a major partner and collaborator in...
Reflections on the Genomics for Australian Plants initiative
The Bioplatforms Genomics for Australian Plants (GAP) Framework Data Initiative was established in December 2018 in partnership with researchers from the Australian State and National Herbaria and Botanic Gardens. The consortium set to develop genomics...
GET IN TOUCH
ADDRESS
Level 4, Building 4WW, Research Park Drive
Macquarie University, NSW 2019, Australia
ABN
40 125 905 599
PHONE
P: +61 410 538 648
F: +61 2 9850 6200
STAFF EMAILS
See team details here.
Bioplatforms Australia is made possible through investment funding provided by the Commonwealth Government National Collaborative Research Infrastructure Strategy (NCRIS).
BOARD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed ligula ipsum, pellentesque et urna dictum, cursus sodales turpis. Praesent vel mauris a ligula pellentesque pulvinar sed vitae massa.